Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3578)
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
275
Price
$545.71
Total Value
$150.07K
Shares Held After
210,759
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
545
Price
$544.71
Total Value
$296.87K
Shares Held After
211,034
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
110
Price
$543.79
Total Value
$59.82K
Shares Held After
211,579
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
140
Price
$542.75
Total Value
$75.98K
Shares Held After
211,689
% of Holdings
0.1%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
12,000
Price
$3.47
Total Value
$41.64K
Shares Held After
986,967
% of Holdings
1.2%
Greenland Mines Ltd (GRML)
McGarity Jon — Director
Shares
140,000
Price
$0.18
Total Value
$24.82K
Shares Held After
551,277
% of Holdings
25.4%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
265
Price
$2.44
Total Value
$646.60
Shares Held After
2,854,337
% of Holdings
0.0%
Rani Therapeutics Holdings, Inc. (RANI)
Imran Talat — Director
Shares
35,000
Price
$0.72
Total Value
$25.19K
Shares Held After
469,736
% of Holdings
7.5%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
63
Price
$53.92
Total Value
$3.40K
Shares Held After
25,000
% of Holdings
0.3%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,184
Price
$53.42
Total Value
$116.67K
Shares Held After
25,063
% of Holdings
8.0%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,063
Price
$52.39
Total Value
$108.08K
Shares Held After
27,247
% of Holdings
7.0%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
459
Price
$51.55
Total Value
$23.66K
Shares Held After
29,310
% of Holdings
1.5%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
231
Price
$50.05
Total Value
$11.56K
Shares Held After
29,769
% of Holdings
0.8%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
123
Price
$53.87
Total Value
$6.63K
Shares Held After
46,054
% of Holdings
0.3%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
2,638
Price
$53.38
Total Value
$140.82K
Shares Held After
46,177
% of Holdings
5.4%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
2,564
Price
$52.32
Total Value
$134.14K
Shares Held After
48,815
% of Holdings
5.0%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
369
Price
$51.48
Total Value
$19.00K
Shares Held After
51,379
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
324
Price
$49.97
Total Value
$16.19K
Shares Held After
51,748
% of Holdings
0.6%
ProQR Therapeutics N.V. (PRQR)
Filius Bart — Director
Shares
150,000
Price
$1.72
Total Value
$257.93K
Shares Held After
300,000
% of Holdings
50.0%
ImageneBio, Inc. (IMA)
Lally Robert B — Principal Accounting Officer
Shares
1,525
Price
$5.34
Total Value
$8.14K
Shares Held After
55,582
% of Holdings
2.7%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
416
Price
$26.53
Total Value
$11.04K
Shares Held After
51,384
% of Holdings
0.8%
Fulcrum Therapeutics, Inc. (FULC)
TANG KEVIN — 10% Owner
Shares
50,945
Price
$3.52
Total Value
$179.33K
Shares Held After
7,080,945
% of Holdings
0.7%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
7,882
Price
$8.95
Total Value
$70.54K
Shares Held After
16,977,927
% of Holdings
0.0%
Aktis Oncology, Inc. (AKTS)
Herrmann Ken — Director
Shares
3,065
Price
$25.21
Total Value
$77.26K
Shares Held After
0
% of Holdings
100.0%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
752
Price
$7.90
Total Value
$5.94K
Shares Held After
51,438
% of Holdings
1.4%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
500
Price
$0.83
Total Value
$415.00
Shares Held After
368,885
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
293
Price
$542.43
Total Value
$158.93K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
892
Price
$542.06
Total Value
$483.52K
Shares Held After
324,736
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
251
Price
$540.69
Total Value
$135.71K
Shares Held After
325,628
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
821
Price
$539.63
Total Value
$443.03K
Shares Held After
325,879
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
423
Price
$538.70
Total Value
$227.87K
Shares Held After
326,700
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,160
Price
$537.45
Total Value
$623.44K
Shares Held After
327,123
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,110
Price
$536.36
Total Value
$1.13M
Shares Held After
328,283
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,350
Price
$535.53
Total Value
$1.26M
Shares Held After
330,393
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
720
Price
$534.57
Total Value
$384.89K
Shares Held After
332,743
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$530.83
Total Value
$127.40K
Shares Held After
333,463
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$528.91
Total Value
$126.94K
Shares Held After
333,703
% of Holdings
0.1%
Lyell Immunopharma, Inc. (LYEL)
Innovative Cellular Therapeutics Holdings Ltd — 10% Owner
Shares
10
Price
$13.70
Total Value
$137.00
Shares Held After
2,857,480
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MLPT)
Kreitzer Anatol — Chief Discovery Officer
Shares
200
Price
$38.39
Total Value
$7.68K
Shares Held After
174,906
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MLPT)
Kreitzer Anatol — Chief Discovery Officer
Shares
14,140
Price
$37.70
Total Value
$533.08K
Shares Held After
175,106
% of Holdings
7.5%
MapLight Therapeutics, Inc. (MLPT)
Kreitzer Anatol — Chief Discovery Officer
Shares
2,833
Price
$37.05
Total Value
$104.96K
Shares Held After
189,246
% of Holdings
1.5%
MapLight Therapeutics, Inc. (MLPT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
900
Price
$38.17
Total Value
$34.35K
Shares Held After
144,240
% of Holdings
0.6%
MapLight Therapeutics, Inc. (MLPT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
16,969
Price
$37.61
Total Value
$638.20K
Shares Held After
145,140
% of Holdings
10.5%
MapLight Therapeutics, Inc. (MLPT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
600
Price
$36.51
Total Value
$21.91K
Shares Held After
162,109
% of Holdings
0.4%
MapLight Therapeutics, Inc. (MLPT)
Kroeger Christopher A. — Director
Shares
16,779
Price
$37.90
Total Value
$635.92K
Shares Held After
1,246,455
% of Holdings
1.3%
MANNKIND CORP (MNKD)
Binder Steven B. — Director
Shares
52,485
Price
$4.06
Total Value
$213.09K
Shares Held After
824,918
% of Holdings
6.0%
MapLight Therapeutics, Inc. (MLPT)
Lillie James Woodruff — Chief Scientific Officer
Shares
2,077
Price
$37.90
Total Value
$78.72K
Shares Held After
224,462
% of Holdings
0.9%
MapLight Therapeutics, Inc. (MLPT)
Foff Erin Pennock — Chief Medical Officer
Shares
3,656
Price
$37.90
Total Value
$138.56K
Shares Held After
298,901
% of Holdings
1.2%
MANNKIND CORP (MNKD)
Thomson David — EVP Genl Counsel&Secretary
Shares
24,109
Price
$4.05
Total Value
$97.64K
Shares Held After
797,554
% of Holdings
2.9%
MapLight Therapeutics, Inc. (MLPT)
Hanson Kristopher — General Counsel
Shares
1,130
Price
$37.90
Total Value
$42.83K
Shares Held After
145,823
% of Holdings
0.8%
Showing 201–250 of 3578 transactions (page 5 of 72)